fluorobenzenes has been researched along with Hepatitis C, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, J; Brown, K; Cates, C; Conrad, A; Elliott, L; George, J; Jhaveri, R; Kenedi, C; Kilaru, R; McHutchison, JG; Patel, K; Qiang, G; Tillmann, HL; Zekry, A | 1 |
1 other study(ies) available for fluorobenzenes and Hepatitis C, Chronic
Article | Year |
---|---|
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.
Topics: Cohort Studies; Female; Fluorobenzenes; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Prospective Studies; Pyrimidines; RNA, Viral; Rosuvastatin Calcium; Statistics as Topic; Sulfonamides | 2011 |